[Corticosteroid sparing agents for polymyalgia rheumatica and arteritis temporalis (Horton's disease)].
Rheumatologe FMH, Sierre. jean-jacques.volken@hrsl.ch
J J
JJ
Volken
W
W
Karrer
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008134:Long-Term Care; D011111:Polymyalgia Rheumatica / Q000175:diagnosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents